A detailed history of First Interstate Bank transactions in Amgen Inc stock. As of the latest transaction made, First Interstate Bank holds 1,164 shares of AMGN stock, worth $362,539. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,164
Previous 1,189 2.1%
Holding current value
$362,539
Previous $342,000 3.51%
% of portfolio
0.02%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $6,721 - $8,114
-25 Reduced 2.1%
1,164 $330,000
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $8,182 - $9,230
-32 Reduced 2.62%
1,189 $342,000
Q3 2023

Oct 31, 2023

BUY
$218.65 - $271.46 $4,373 - $5,429
20 Added 1.67%
1,221 $328,000
Q2 2023

Aug 01, 2023

SELL
$214.27 - $253.37 $5,356 - $6,334
-25 Reduced 2.04%
1,201 $266,000
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $16,032 - $20,370
-70 Reduced 5.4%
1,226 $322,000
Q3 2022

Oct 25, 2022

BUY
$224.46 - $253.15 $37,933 - $42,782
169 Added 15.0%
1,296 $292,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $10,612 - $11,810
-46 Reduced 3.92%
1,127 $274,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $4,604 - $5,093
-21 Reduced 1.76%
1,173 $284,000
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $8,551 - $9,786
-43 Reduced 3.48%
1,194 $269,000
Q3 2021

Nov 01, 2021

BUY
$212.27 - $248.7 $26,533 - $31,087
125 Added 11.24%
1,237 $263,000
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $18,608 - $22,159
-86 Reduced 7.18%
1,112 $256,000
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $186,312 - $207,194
-794 Reduced 39.86%
1,198 $304,000
Q2 2020

Aug 05, 2020

SELL
$197.81 - $242.74 $108,399 - $133,021
-548 Reduced 21.57%
1,992 $470,000
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $22,051 - $29,245
121 Added 5.0%
2,540 $514,000
Q4 2019

Feb 06, 2020

SELL
$189.21 - $243.2 $24,786 - $31,859
-131 Reduced 5.14%
2,419 $583,000
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $65,117 - $78,023
-374 Reduced 12.79%
2,550 $494,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $30,672 - $35,955
-184 Reduced 5.92%
2,924 $538,000
Q1 2019

May 02, 2019

SELL
$180.87 - $203.88 $226,087 - $254,850
-1,250 Reduced 28.68%
3,108 $590,000
Q4 2018

Jan 31, 2019

BUY
$178.4 - $208.25 $105,791 - $123,492
593 Added 15.75%
4,358 $848,000
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $46,137 - $52,013
-249 Reduced 6.2%
3,765 $780,000
Q2 2018

Jul 27, 2018

SELL
$166.05 - $186.51 $47,490 - $53,341
-286 Reduced 6.65%
4,014 $740,000
Q1 2018

Apr 26, 2018

SELL
$169.43 - $198.0 $40,154 - $46,926
-237 Reduced 5.22%
4,300 $733,000
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $314,455 - $351,343
-1,863 Reduced 29.11%
4,537 $789,000
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $1.07 Million - $1.22 Million
6,400
6,400 $1.19 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First Interstate Bank Portfolio

Follow First Interstate Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Interstate Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Interstate Bank with notifications on news.